Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2

Caterina Tatarelli, Alban Linnenbach, Koshi Mimori, Carlo M. Croce

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Cancer-associated chromosomal aberrations often involve regions containing fragile sites. FRA7G is a common aphidicolin-inducible fragile site at 7q31.2, showing loss of heterozygosity in human malignancies. To investigate the structure of FRA7G, we constructed a bacterial artificial chromosome contig spanning the region between marker D7S486 and Met H. Analysis of the FRA7G sequence allowed us to identify a gene encoding a 421-amino-acid protein with three LIM domains and 89% identity to murine Testin. We determined the genomic structure of the human TESTIN locus and characterized three alternative transcripts. Although TESTIN mRNA is expressed in all normal human tissues examined, we observed lack of expression in 22% of cancer cell lines and 44% of the cell lines derived from hematological malignancies. We further determined that in most of these cases the inactivation of TESTIN expression is due to methylation of a CpG island. Analysis of the TESTIN coding region in 26 tumor cell lines revealed three missense mutations. Our findings suggest that TESTIN may represent a candidate tumor suppressor gene at 7q31.2. (C) 2000 Academic Press.

Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalGenomics
Volume68
Issue number1
DOIs
Publication statusPublished - Aug 15 2000
Externally publishedYes

Fingerprint

Aphidicolin
Genes
Bacterial Artificial Chromosomes
Cell Line
Neoplasms
CpG Islands
Loss of Heterozygosity
Hematologic Neoplasms
Missense Mutation
Tumor Cell Line
Tumor Suppressor Genes
Chromosome Aberrations
Methylation
Sequence Analysis
Amino Acids
Messenger RNA
Proteins

All Science Journal Classification (ASJC) codes

  • Genetics

Cite this

Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2. / Tatarelli, Caterina; Linnenbach, Alban; Mimori, Koshi; Croce, Carlo M.

In: Genomics, Vol. 68, No. 1, 15.08.2000, p. 1-12.

Research output: Contribution to journalArticle

Tatarelli, Caterina ; Linnenbach, Alban ; Mimori, Koshi ; Croce, Carlo M. / Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2. In: Genomics. 2000 ; Vol. 68, No. 1. pp. 1-12.
@article{77fcdb0cb2ec4fcfa01d1830ec9e740f,
title = "Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2",
abstract = "Cancer-associated chromosomal aberrations often involve regions containing fragile sites. FRA7G is a common aphidicolin-inducible fragile site at 7q31.2, showing loss of heterozygosity in human malignancies. To investigate the structure of FRA7G, we constructed a bacterial artificial chromosome contig spanning the region between marker D7S486 and Met H. Analysis of the FRA7G sequence allowed us to identify a gene encoding a 421-amino-acid protein with three LIM domains and 89{\%} identity to murine Testin. We determined the genomic structure of the human TESTIN locus and characterized three alternative transcripts. Although TESTIN mRNA is expressed in all normal human tissues examined, we observed lack of expression in 22{\%} of cancer cell lines and 44{\%} of the cell lines derived from hematological malignancies. We further determined that in most of these cases the inactivation of TESTIN expression is due to methylation of a CpG island. Analysis of the TESTIN coding region in 26 tumor cell lines revealed three missense mutations. Our findings suggest that TESTIN may represent a candidate tumor suppressor gene at 7q31.2. (C) 2000 Academic Press.",
author = "Caterina Tatarelli and Alban Linnenbach and Koshi Mimori and Croce, {Carlo M.}",
year = "2000",
month = "8",
day = "15",
doi = "10.1006/geno.2000.6272",
language = "English",
volume = "68",
pages = "1--12",
journal = "Genomics",
issn = "0888-7543",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2

AU - Tatarelli, Caterina

AU - Linnenbach, Alban

AU - Mimori, Koshi

AU - Croce, Carlo M.

PY - 2000/8/15

Y1 - 2000/8/15

N2 - Cancer-associated chromosomal aberrations often involve regions containing fragile sites. FRA7G is a common aphidicolin-inducible fragile site at 7q31.2, showing loss of heterozygosity in human malignancies. To investigate the structure of FRA7G, we constructed a bacterial artificial chromosome contig spanning the region between marker D7S486 and Met H. Analysis of the FRA7G sequence allowed us to identify a gene encoding a 421-amino-acid protein with three LIM domains and 89% identity to murine Testin. We determined the genomic structure of the human TESTIN locus and characterized three alternative transcripts. Although TESTIN mRNA is expressed in all normal human tissues examined, we observed lack of expression in 22% of cancer cell lines and 44% of the cell lines derived from hematological malignancies. We further determined that in most of these cases the inactivation of TESTIN expression is due to methylation of a CpG island. Analysis of the TESTIN coding region in 26 tumor cell lines revealed three missense mutations. Our findings suggest that TESTIN may represent a candidate tumor suppressor gene at 7q31.2. (C) 2000 Academic Press.

AB - Cancer-associated chromosomal aberrations often involve regions containing fragile sites. FRA7G is a common aphidicolin-inducible fragile site at 7q31.2, showing loss of heterozygosity in human malignancies. To investigate the structure of FRA7G, we constructed a bacterial artificial chromosome contig spanning the region between marker D7S486 and Met H. Analysis of the FRA7G sequence allowed us to identify a gene encoding a 421-amino-acid protein with three LIM domains and 89% identity to murine Testin. We determined the genomic structure of the human TESTIN locus and characterized three alternative transcripts. Although TESTIN mRNA is expressed in all normal human tissues examined, we observed lack of expression in 22% of cancer cell lines and 44% of the cell lines derived from hematological malignancies. We further determined that in most of these cases the inactivation of TESTIN expression is due to methylation of a CpG island. Analysis of the TESTIN coding region in 26 tumor cell lines revealed three missense mutations. Our findings suggest that TESTIN may represent a candidate tumor suppressor gene at 7q31.2. (C) 2000 Academic Press.

UR - http://www.scopus.com/inward/record.url?scp=0034662782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034662782&partnerID=8YFLogxK

U2 - 10.1006/geno.2000.6272

DO - 10.1006/geno.2000.6272

M3 - Article

C2 - 10950921

AN - SCOPUS:0034662782

VL - 68

SP - 1

EP - 12

JO - Genomics

JF - Genomics

SN - 0888-7543

IS - 1

ER -